- Home
- KRMD vs BWAY Comparison
KRMD vs BWAY Comparison
Compare KRMD & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- BWAY
- Stock Information
- Founded
- KRMD 1980
- BWAY 2003
- Country
- KRMD United States
- BWAY Israel
- Employees
- KRMD N/A
- BWAY N/A
- Industry
- KRMD Medical/Dental Instruments
- BWAY Medical/Dental Instruments
- Sector
- KRMD Health Care
- BWAY Health Care
- Exchange
- KRMD Nasdaq
- BWAY Nasdaq
- Market Cap
- KRMD 187.5M
- BWAY 177.4M
- IPO Year
- KRMD N/A
- BWAY 2019
- Fundamental
- Price
- KRMD $4.60
- BWAY $10.28
- Analyst Decision
- KRMD Strong Buy
- BWAY Strong Buy
- Analyst Count
- KRMD 5
- BWAY 3
- Target Price
- KRMD $4.50
- BWAY $13.17
- AVG Volume (30 Days)
- KRMD 157.7K
- BWAY 57.5K
- Earning Date
- KRMD 03-12-2025
- BWAY 03-05-2025
- Dividend Yield
- KRMD N/A
- BWAY N/A
- EPS Growth
- KRMD N/A
- BWAY N/A
- EPS
- KRMD N/A
- BWAY 0.04
- Revenue
- KRMD $31,993,796.00
- BWAY $38,631,000.00
- Revenue This Year
- KRMD $20.04
- BWAY $388.82
- Revenue Next Year
- KRMD $14.15
- BWAY $18.70
- P/E Ratio
- KRMD N/A
- BWAY $128.37
- Revenue Growth
- KRMD 11.57
- BWAY 34.19
- 52 Week Low
- KRMD $2.01
- BWAY $4.61
- 52 Week High
- KRMD $5.05
- BWAY $11.25
- Technical
- Relative Strength Index (RSI)
- KRMD 66.80
- BWAY 46.35
- Support Level
- KRMD $4.16
- BWAY $10.24
- Resistance Level
- KRMD $4.40
- BWAY $10.89
- Average True Range (ATR)
- KRMD 0.23
- BWAY 0.47
- MACD
- KRMD 0.03
- BWAY -0.04
- Stochastic Oscillator
- KRMD 63.71
- BWAY 10.34
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.